There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

Novavax is working with the FDA to meet additional requirements and hopes to secure full approval as soon as possible.

Kennedy Jr cast doubt on its efficacy. The Novavax vaccine is the only COVID-19 booster in the United States that does not use messenger RNA technology - which some states have begun to ban - and ...

The Novavax Covid-19 vaccine, which uses more traditional protein-based technology than the newer mRNA vaccines from Pfizer/BioNTech and Moderna, has been subject to emergency use authorization ...

WASHINGTON (AP) — Novavax’s closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug Administration, the company said Wednesday.

Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday. The update sent Novavax's stock up more than 21% in early ...

HEALTH. ED TO YOU. LET’S PICK IT UP RIGHT THERE. MARIA. HERE TO DISCUSS SOME MORE. IS DOCTOR TODD AND FAMILIAR FACE HERE AT 430 ON NEWSCENTER 5. CHIEF OF INFECTIOUS DISEASES AT SOUTH SHORE HEALTH.

Novavax (NVAX.O), opens new tab said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full approval, sending the drugmaker's shares soaring ...